Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Aurora Cannabis

Canopy Growth

The grass won't necessarily be greener for the weed industry anytime soon.

Canadian Marijuana Sales Hit an All-Time High in April (but Still Disappoint)

Cronos Group should benefit from the Altria investment and the growth of the cannabis industry, but CRON stock will struggle to benefit.
The post What Is Good For Cronos Group Will Likely Not Benefit Cronos Stock appeared first on InvestorPlace.

What Is Good For Cronos Group Will Likely Not Benefit Cronos Stock

CannTrust Holdings

HEXO Corp

Perhaps unsurprisingly, derivative cannabis products won't launch on time.

Health Canada Just Failed the Marijuana Industry... Again

In the latest trading session, Cronos Group (CRON) closed at $15.79, marking a -1.86% move from the previous day.

Cronos Group (CRON) Dips More Than Broader Markets: What You Should Know

Despite being a top-performing pot stock since 2016, Cronos Group still has a lot to prove to Wall Street and investors.

3 Reasons to Wait on Cannabis Favorite Cronos Group

Canopy Growth and Cronos Group expressed reservations about Canada's THC limits on cannabis-infused edibles and beverages. Most marijuana stocks fell.

Marijuana Stocks: Canopy, Cronos Officials See These Problems In Canada's THC Limits

GW Pharmaceuticals

Scotts Miracle-Gro

The marijuana industry has strong potential especially after its legalization for recreational and medicinal use.

Breakthrough in U.S. Marijuana Industry: 5 Likely Gainers

CRON stock is the most richly valued stock in one of the most richly valued sectors, and the risk-reward ratio of Cronos stock is negative..
The post Why Cronos Group Stock Still Looks Overvalued appeared first on InvestorPlace.

Why Cronos Group Stock Still Looks Overvalued

Aphria

Three marijuana stocks worth more than $1 billion that look more like acquisition targets than acquirers.

These Billion-Dollar Pot Stocks Are Buyout Candidates

CGC analysts are estimating an EPS of -0.17 and revenues of $71 million. Shareholders are voting today on whether to acquire Acreage Holdings, which could propel CGC one way or the other.

Canopy Growth Earnings After Bell 6/20: Key Word Growth

Marijuana may not have investors seeing much green through 2020.

Profit Projections Are Still Plunging for the 3 Most Popular Pot Stocks

Tilray Brands

Greenlane Holdings

Innovative Industrial Properties

Village Farms International

There's one big reason pessimism has been building for a number of popular marijuana stocks.

Short Interest Soared in May for These 8 Pot Stocks

Cronos may have $2 billion in cash but it is strategic in the way it spends that. So far the right moves are helping Cronos stock.

After a Bumpy Few Months, Cronos Stock Is Back on the Move

Lower-valued American cannabis stocks are set to outperform their Canadian rivals as U.S. legal pot sales outpace those north of the border.

Why 5 U.S. Cannabis Stocks Will Outperform Amid Federal Ban

Millennials love cannabis stocks. Unfortunately, two of their favorites could be duds.

4 of the 14 Most Widely Held Stocks on Investing App Robinhood Are Marijuana Stocks

Ashford Hospitality Trust

Fiverr

Some stocks took much bigger hits than the overall market did to close the week.

Why Cronos Group, Fiverr International, and Ashford Hospitality Trust Slumped Today

The best stocks in the pot sector might be the medical marijuana plays. These 3 medical marijuana stocks should have big upside.

Three Medical Marijuana Stocks - to Buy.

CRON stock has a solid band of support so the bulls can mount a 20% rally from here. The bears are at a disadvantage.

Cronos Group Stock Is Just Getting Started

This month, Cronos stock seems to have found round number support at $14 and is rallying hard off that level. 
The post Cronos Stock Could Be Worth the Bumpy Ride appeared first on InvestorPlace.

Cronos Stock Could Be Worth the Bumpy Ride

MongoDB

Twilio

Don’t write these names off because you think you’ve missed the boat.

Three Stocks That Have Doubled and Still Have Room to Grow.

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Raise Their Bets in Cannabis Stocks

If I were a Wall Street firm, I'd have little issue handing out sell ratings to these popular pot stocks.

3 Pot Stocks Deserving of a Sell Rating

Cannabis investing emerged as a clear trend in the past year, with marijuana stocks accounting for a fifth of the 20 most-held stocks on the Robinhood app.

These Marijuana Stocks Are Smoking Hot Among Millennial Investors

While many are hating on Cronos Group, one analyst thinks the company is poised to be a big winner in the U.S.

Why Much-Maligned Cronos Group Could Be a Sleeping Giant

Axon Enterprise

Advanced Micro Devices

Roku

Stitch Fix

Snap

Wayfair

In the stock market, it's always the underdogs that end up being the biggest winners, and these dark horse stocks are the top underdogs of 2019.

News for Cronos Group Stock (CRON)